The Wyss Institute for Biologically Inspired Engineering at Harvard has been awarded a $12.3 million, four-year grant from the Defense Advanced Research Projects Agency (DARPA) to develop a treatment for sepsis, a commonly fatal bloodstream infection. Sepsis is a major cause of injury and death among combat-injured soldiers in the field, as well as patients in hospital intensive care units. The proposed treatment would involve a miniaturized, dialysislike device that could rapidly clear the blood of a wide range of pathogens, much as a living human spleen does, without removing normal blood cells, proteins, fluids, or electrolytes. This novel “Spleen-on-a-Chip” would be portable, self-contained, and easily inserted into the peripheral blood vessels of a septic patient or soldier. The award, which was announced Sept. 28, is part of DARPA’s Dialysis Like Therapeutics (DLT) program, which seeks to develop ways to dramatically decrease the morbidity and mortality of sepsis. Worldwide, more than 18...
- Doctors to treat septic patients with hypothermiaWed, 30 Jun 2010, 18:36:43 EDT
- Trudeau Institute announces a discovery in the fight against sepsisMon, 11 Jul 2011, 13:33:53 EDT
- Surviving sepsis program -- increased compliance gets resultsThu, 3 Sep 2009, 6:29:04 EDT
- Researchers block immune cell rush behind deadly sepsisTue, 24 Feb 2009, 15:58:16 EST
- Therapy helps improve outcomes for patients with severe sepsisTue, 16 Jun 2009, 22:52:32 EDT